A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

Autor: Ma, B.B.Y. *, Kam, M.K.M., Leung, S.F., Hui, E.P., King, A.D., Chan, S.L., Mo, F., Loong, H., Yu, B.K.H., Ahuja, A., Chan, A.T.C.
Zdroj: In Annals of Oncology May 2012 23(5):1287-1292
Databáze: ScienceDirect